Unique ID issued by UMIN | UMIN000035226 |
---|---|
Receipt number | R000040141 |
Scientific Title | Clinical trial to evaluate Pholiota adiposa intake on serum glucose level after glucose load in healthy human. |
Date of disclosure of the study information | 2018/12/12 |
Last modified on | 2018/12/12 00:01:53 |
Clinical trial to evaluate Pholiota adiposa intake on serum glucose level after glucose load in healthy human.
Clinical trial with Pholiota adiposa
Clinical trial to evaluate Pholiota adiposa intake on serum glucose level after glucose load in healthy human.
Clinical trial with Pholiota adiposa
Japan |
Healthy person
Adult |
Others
NO
The objective of this study is to evaluate the efficacy of Pholiota adiposa intake on serum glucose level after meal.
Efficacy
Confirmatory
Not applicable
glucose level (at min-0, min-30, min-60 and min-120)
AUC of glucose level
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Placebo
No need to know
2
Prevention
Food |
Cooked Pholiota adipose,
25 g/meal, 50 g/meal,
Once a day
Placebo containing the three major nutrients 25 g/meal, 50 g/meal
20 | years-old | <= |
60 | years-old | > |
Male and Female
(1) Non smokers
(2) Persons who will generally be judged as healthy
(3) Persons who have never suffered from asthma
(4) Persons who have never developed any allegic reaction to medicines, foods, or other substances.
(5) Persons who will give written informed consent by theirselves
1) Persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study.
(2) Persons who changed their habitats of supplements within 4 weeks.
(3) Persons who work in night shift or in day and night shift.
(4) Persons who have been treated their illness or prevention in a clinic at their informed consent
persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolismliver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system.
(6) Persons with the medical histories of alcoholism or drug dependence.
(7) Prsons who might be developed allergic reaction to foods.
(8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study period.
(9) Persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)
(10) Persons who will not be judged suitable to the participants by the investigator.
10
1st name | |
Middle name | |
Last name | Koichiro Ohnuki |
Kindai University
Department of Biological & Environmental
11-6, Kayanomori, Iizukacity, Fukuoka
0948-22-5655
ohnuki@fuk.kindai.ac.jp
1st name | |
Middle name | |
Last name | Koichiro Ohnuki |
Kindai University
Department of Biological & Environmental
11-6, Kayanomori, Iizukacity, Fukuoka
0948-22-5655
ohnuki@fuk.kindai.ac.jp
Kinki University
Department of Biological & Environmental Chemistry
Faculty of Human-Oriented Science and Engineering
Judicial agricultural union Dream mash
Profit organization
Faculty of Agriculture, Kyushu University
NO
2018 | Year | 12 | Month | 12 | Day |
Unpublished
Completed
2017 | Year | 10 | Month | 10 | Day |
2017 | Year | 10 | Month | 17 | Day |
2018 | Year | 12 | Month | 12 | Day |
2018 | Year | 12 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040141